PRP intraovarian injection improves the number and quality of blastocysts in mouse models

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science), Volume 16, Issue 17 on September 13, 2024, entitled, “Intraovarian PRP injection improves oocyte quality and early embryo development in mouse models of chemotherapy-induced diminished ovarian reserve.”

Clinical trial trends in 2025: Investments, wearables, and AI

Digital solutions offer clinical trials multiple possibilities. Credit: via Shutterstock. 2025 is set to be another significant year for clinical trials. According to GlobalData’s Clinical

January 8, 2025

Race- and gender-specific interventions may be more effective at preventing overdose deaths

Interventions to address stimulant and opioid use that consider race and gender may prove more effective at preventing overdose deaths than current methods, according to

June 26, 2023

Oncternal stock crashes by 60% as it lays off staff and scraps trials – Pharmaceutical Technology

Oncternal Therapeutics is laying off about ten employees, representing approximately 37% of its workforce. Credit: Andrii Yalanskyi via Shutterstock. Oncternal Therapeutics’s stock has slumped after

September 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.